THR(THR)
THR
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $557M | $591M |
| Low | $551M | $590M |
| High | $566M | $592M |
| EBITDA Avg | $111M | $118M |
| Low | $110M | $118M |
| High | $113M | $119M |
| EBIT Avg | $106M | $112M |
| Low | $105M | $112M |
| High | $108M | $113M |
| Net Income Avg | $74M | $83M |
| Low | $71M | $78M |
| High | $78M | $88M |
| EPS Avg | $2.26 | $2.49 |
| Low | $2.13 | $2.33 |
| High | $2.34 | $2.64 |
| Analysts (Rev / EPS) | 3 / 3 | 2 / 2 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $117M | $139M | $154M | $147M | $129M | $151M | $164M | $157M |
| Low | $117M | $139M | $152M | $145M | $128M | $149M | $161M | $155M |
| High | $118M | $140M | $156M | $149M | $131M | $154M | $166M | $159M |
| EBITDA Avg | $23M | $28M | $31M | $29M | $26M | $30M | $33M | $31M |
| Low | $23M | $28M | $30M | $29M | $26M | $30M | $32M | $31M |
| High | $24M | $28M | $31M | $30M | $26M | $31M | $33M | $32M |
| EBIT Avg | $22M | $27M | $29M | $28M | $25M | $29M | $31M | $30M |
| Low | $22M | $26M | $29M | $28M | $24M | $28M | $31M | $29M |
| High | $22M | $27M | $30M | $28M | $25M | $29M | $32M | $30M |
| Net Income Avg | $13M | $18M | $22M | $20M | $14M | $21M | $26M | $23M |
| Low | $12M | $17M | $22M | $20M | $14M | $21M | $25M | $22M |
| High | $14M | $20M | $23M | $20M | $14M | $22M | $26M | $23M |
| EPS Avg | $0.39 | $0.55 | $0.67 | $0.60 | $0.42 | $0.64 | $0.77 | $0.68 |
| Low | $0.36 | $0.51 | $0.66 | $0.59 | $0.41 | $0.63 | $0.76 | $0.67 |
| High | $0.41 | $0.59 | $0.69 | $0.61 | $0.43 | $0.65 | $0.78 | $0.69 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |